EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genomic Landscape Analysis of Canine Pulmonary Adenocarcinoma Reveals Candidate Targetable Gene Fusions

Sharadha Sakthikumar iD, William P D Hendricks iD, David Rainford, William Selleck, Natalia Briones, Christopher Coggins, Natalie Quan, Victoria Zismann, Gwendolen Lorch iD, Aleksandar Sekulic, Jeffrey M Trent

Veterinary and Comparative Oncology · 2026-06 · 24 (2) · 393-406

DOI: 10.1111/vco.70063 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary and Comparative Oncology, online erschienen am 31.03.2026. Verfasst von Sharadha Sakthikumar und 10 weiteren Autor:innen. Beteiligte Einrichtung: Translational Genomics Research Institute, Phoenix, Arizona, USA. Hauptthemen laut MEDLINE: Adenocarcinoma of Lung, Dog Diseases, Lung Neoplasms, Oncogene Fusion. Die Arbeit nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Canine Cancer Foundation, National Institutes of Health, National Center for Advancing Translational Sciences, NCI NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Spontaneously occurring primary canine pulmonary adenocarcinoma (cPAC) exhibits clinicopathological and molecular similarities to never‐smoker human lung cancers. Shared genomic alterations, including point mutations, indel mutations and copy number changes particularly in HER2 signalling, are significant therapeutic targets, especially for HER2 and tyrosine kinase inhibitors. Whilst progress has been made in identifying mutational drivers in canine cancers, the role of somatic gene fusions in cPAC remains poorly understood, despite their importance in other cancers as drivers and therapeutic targets. This study investigates the fusion landscape in cPAC by analysing RNA‐seq data from a cohort of 36 primary tumour samples and reports oncogenic fusions with therapeutic potential. Notably, NRG1 fusions were identified in a subset of tumours, including recurrent SDC4::NRG1 events, potentially playing key roles in disease progression. NRG1 fusions, known to activate HER2 signalling, are mutually exclusive with HER2 gene alterations, indicating convergence on the same pathway. Tumours with SDC4::NRG1 fusions also overexpress HER2 pathway‐related genes, reinforcing NRG1‐driven activation. Similar fusions occur in never‐smoker human non‐small cell adenocarcinoma lacking other common drivers, underscoring their therapeutic importance. These findings highlight NRG1 fusions as critical contributors to cPAC tumorigenesis and warrant further clinical and comparative investigation. Additionally, novel fusions disrupting the PTEN axis were identified, leading to truncated PTEN and associated protein domains. These disruptions could impair tumour‐suppressive pathways, presenting additional therapeutic targets. This research emphasises the broader relevance of fusion‐driven mechanisms in cPAC tumorigenesis, advancing the understanding of both canine and human lung cancers for clinical and comparative studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Adenocarcinoma of LungDog DiseasesLung NeoplasmsOncogene FusionAnimalsDogsFemaleMaleGenes, erbB-2Translocation, GeneticNeuregulin-1

Stichwörter der Autor:innen

NSCLCcPACcancerdogsfusionspulmonary adenocarcinoma

Substanzen

Neuregulin-1

Autor:innen und Institutionen

  • Translational Genomics Research Institute, Phoenix, Arizona, USA.
  • MedVet, Columbus, Ohio, USA.

ORCID-Profile: Sharadha Sakthikumar, William P D Hendricks, Gwendolen Lorch

Förderung

  • National Canine Cancer Foundation
  • National Institutes of Health, National Center for Advancing Translational Sciences
  • NCI NIH HHS
  • Brooke's Blossoming Hope
  • Petco Love
  • Blue Buffalo Foundation for Cancer Research Inc
  • National Institutes of Health
  • National Cancer Institute

Zitieren

APA

Sakthikumar, S., Hendricks, W. P. D., Rainford, D., Selleck, W., Briones, N., Coggins, C., Quan, N., Zismann, V., Lorch, G., Sekulic, A., & Trent, J. M. (2026). Genomic Landscape Analysis of Canine Pulmonary Adenocarcinoma Reveals Candidate Targetable Gene Fusions. Veterinary and Comparative Oncology, 24(2), 393-406. https://doi.org/10.1111/vco.70063

Vancouver

Sakthikumar S, Hendricks WPD, Rainford D, Selleck W, Briones N, Coggins C, et al. Genomic Landscape Analysis of Canine Pulmonary Adenocarcinoma Reveals Candidate Targetable Gene Fusions. Veterinary and Comparative Oncology. 2026;24(2):393-406. doi:10.1111/vco.70063

BibTeX
@article{Sakthikumar2026,
  author = {Sakthikumar, Sharadha and Hendricks, William P D and Rainford, David and Selleck, William and Briones, Natalia and Coggins, Christopher and Quan, Natalie and Zismann, Victoria and Lorch, Gwendolen and Sekulic, Aleksandar and Trent, Jeffrey M},
  title = {Genomic Landscape Analysis of Canine Pulmonary Adenocarcinoma Reveals Candidate Targetable Gene Fusions},
  journal = {Veterinary and Comparative Oncology},
  year = {2026},
  volume = {24},
  number = {2},
  pages = {393--406},
  doi = {10.1111/vco.70063}
}
Kostenlos starten →